UNIT 6-10, ZEUS BUILDING, DIDCOT, X0
News
Material disclosure
Provides Update on Proposed Combination with Clywedog Therapeutics
Reports Second Quarter 2026 Financial Results and Updates on Corporate Developments
Annual Report to Security Holders
Shareholder Meeting Held; Matters Submitted to Vote on May 20, 2026
Reports First Quarter 2026 Financial Results and Updates on Corporate Developments
Q2
Q1
FY 2025
Q3
FY 2024
Notice of Suspension of Duty to File Reports
Effectiveness Notice
SEC Form 25 - Delisting Notification
Prospectus Filed Pursuant to Rule 425
Registration Statement for Securities to be Offered to Employees
Definitive Proxy Statement
Definitive Merger Proxy Statement
Additional Proxy Materials
PRE 14A
Amended Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Post-Effective Amendment to Registration Statement
S-8 POS
Correspondence